FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAgentix Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AGTX
Agentix Corp. Stock AnalysisComprehensive stock analysis for Agentix Corp. (AGTX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAGTX
AGTX
Agentix Corp.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AGTX
  1. Home
  2. Stocks
  3. Agentix Corp.

Agentix Corp.

🇺🇸AGTX•OTC

Agentix Corp.

🇺🇸AGTX•OTC
Market cap
$1.95M

Your view on AGTX

Mkt Cap
$1.95M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Agentix Corp.

Industry
Biotechnology
Sector
Healthcare
CEO
Riazul Huda
Headquarters
32932 Pacific Coast Highway, Dana Point, CA, US
Industry
Biotechnology
Sector
Healthcare
CEO
Riazul Huda
Headquarters
32932 Pacific Coast Highway, Dana Point, CA, US
Description

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases.

Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases.

The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Agentix Corp.. Starting points for Agentix Corp.: EPS -$0.0091, beta 0.81 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Agentix Corp.. Agentix Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Agentix Corp.. Trailing twelve-month EPS for Agentix Corp. stands at -$0.0091. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Agentix Corp.. Agentix Corp. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold AGTX20 companies
Compare AGTX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
ABTIAlterola Biotech, Inc.HealthcareDrug Manufacturers - Specialty & Generic$7.4M
ACBMAcro Biomedical Co., Ltd.HealthcareMedical - Pharmaceuticals$1.3M
ACHFFArch Biopartners Inc.HealthcareBiotechnology$41.0M
ADMTADM Tronics Unlimited, Inc.HealthcareMedical - Devices$6.8M
ADTXAditxt, Inc.HealthcareBiotechnology$498,988
ADYXAdynxx, Inc.HealthcareBiotechnology$581
ARCTArcturus Therapeutics Holdings Inc.HealthcareBiotechnology$214.7M
RVPHReviva Pharmaceuticals Holdings, Inc.HealthcareBiotechnology$36.3M
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
PAR.AXParadigm Biopharmaceuticals LimitedHealthcareASX—
PARDPoniard Pharmaceuticals, Inc.HealthcareOTC$150
PASGPassage Bio, Inc.HealthcareNASDAQ$12.6M
PBIGFParadigm Biopharmaceuticals LimitedHealthcareOTC$87.9M
PBLAPanbela Therapeutics, Inc.HealthcareOTC$53,889
PBLSParabilis Medicines, Inc.HealthcareNASDAQ$3.3B
PBMPsyence Biomedical Ltd.HealthcareNASDAQ$56,486
PBMWWPsyence Biomedical Ltd. WarrantHealthcareNASDAQ$973
PBYIPuma Biotechnology, Inc.HealthcareNASDAQ$364.5M
PCSAProcessa Pharmaceuticals, Inc.HealthcareNASDAQ$4.4M
PCVXVaxcyte, Inc.HealthcareNASDAQ$8.8B
PDSBPDS Biotechnology CorporationHealthcareNASDAQ$43.4M
Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Agentix Corp. executives and directors. Shares of Agentix Corp. have traded between $0.02 and $0.10 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Agentix Corp.

AGTX AnalysisWeak
Past
1
Growth
2
Health
1
Profit
1
Value
1